Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002336 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002336 is a NA study that has completed, run by Abbott.
The verdict
NCT00002336, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
Interventions
- DRUG Clarithromycin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-11 |
| Est. Completion | 1994-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002336
The ClinicalTrials.gov registry entry for NCT00002336 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clarithromycin is the first listed.
NCT00002336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002336 about?
NCT00002336 is a clinical study titled "The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients". To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.
What is the current status of trial NCT00002336?
This trial is currently completed. It is a NA study. The study started on 1992-11. Estimated completion is 1994-11.
What interventions are being tested in trial NCT00002336?
The interventions under investigation include: Clarithromycin (DRUG).
Who is sponsoring clinical trial NCT00002336?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.